Search Results
Found 1 results
510(k) Data Aggregation
(265 days)
ODFS Pace XL
The ODFS® Pace XL is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of upper motor neuron injury. By detecting the swing phase of gait through a foot switch signal, appropriate electrical stimulation of the leg and ankle muscles may improve gait by flexing the foot of persons who have lost or impaired function. There may be additional benefits from FES such as muscle re-education, prevention/retardation of disuse atrophy, increased or maintained range of joint motion and increase in local blood flow.
The ODFS® Pace XL is a medical device and should only be used under medical supervision for the treatment of dropped foot following an upper motor neuron injury.
The ODFS® Pace XL is an external functional neuromuscular stimulator. It consists of a small, body worn, battery powered, single channel stimulator which is triggered by a footswitch worn in the shoe. The footswitch options are:
- Shoe insole incorporating wireless transceiver which provides wireless triggering
- 'Out of shoe' wireless transceiver with 'in shoe' heel switch. Provides wireless triggering.
- Wired 'in shoe' heel switch for where 1 & 2 are not appropriate or to cover an emergency, e.g. loss of battery power in wireless accessory.
The triggering element and detection is the same across all options and option 3 is common to the ODFS® Pace (predicate device).
Electrical pulses are generated by the device in order to stimulate muscle contractions in the lower limb. (Neuromuscular stimulation) Triggering with a footswitch permits the stimulation to be varied according to the gait of the user. Stimulation produces contraction of the appropriate muscles to cause dorsiflexion of the ankle in individuals who have impaired or absent ability to pick up their foot during walking as a result of a neurological injury. This paralysis affecting the foot is commonly known as 'drop foot' or 'dropped foot'.
The electrical stimulation is delivered via self adhesive skin surface electrodes. The electrodes may be flexibly placed according to the optimum response of the patient but typically are located over the common peroneal nerve as it passes near the head of the fibula. The user may be offered the below knee ODFS® Leg Cuff accessory as aid to locating electrodes repeatedly day to day. An additional option is to mount the ODFS® Pace XL upon the ODFS® Leg Cuff.
For individuals presenting with weakness and/or spasticity a muscle stimulation exercise program can be delivered by the ODFS® Pace XL. In this case the footswitch trigger is not used and the ODFS® Pace functions as a powered muscle stimulator. A clinician would determine the need for this application which can be enabled from a setup option in the ODFS® Pace XL. (Default is to have the exercise disabled)
The Odstock Medical Ltd ODFS® Pace XL device is a functional neuromuscular stimulator. The acceptance criteria and the study that proves the device meets the acceptance criteria are described below.
1. Table of acceptance criteria and the reported device performance:
The provided document K171396 is a 510(k) premarket notification of intent to market the ODFS® Pace XL. This submission does not define specific "acceptance criteria" in the sense of predefined numerical targets that the device must achieve in a clinical trial. Instead, the submission demonstrates "substantial equivalence" to legally marketed predicate devices by showing that the ODFS® Pace XL has the same intended use and similar technological characteristics, and that any differences do not raise new questions of safety and effectiveness.
The "performance data" provided focuses on the electrical output specifications of the device and its compliance with recognized standards. The comparison is primarily against the ODFS® Pace (K102115) and ODFS® III v6.2 (K050991) predicate devices.
Feature / Acceptance Criteria | ODFS® Pace XL Reported Performance | Predicate Device (ODFS® Pace) Performance | Predicate Device (ODFS® III v6.2) Performance |
---|---|---|---|
Intended Use | Same as predicate | Same as predicate | Primary predicate |
Waveform | Biphasic (symmetrical and balanced asymmetrical) | Biphasic (symmetrical and balanced asymmetrical) | Biphasic (symmetrical and balanced asymmetrical) |
Pulsewidth | 0 - 360 microseconds (±10%) | 0 - 360 microseconds (±10%) | 7 - 365 microseconds (±10%) |
Frequency | Default 40Hz, 20-60Hz in 5Hz steps | Default 40Hz, 20-60Hz in 5Hz steps | 40Hz ± 10% |
Max Output Voltage | 86-140V peak (dependent on resistance) | 85-150V peak (dependent on resistance) | (Not explicitly stated in comparable format) |
Max Output Current | 172mA @ 500R, 62mA @ 2K, 14mA @ 10K | 170mA @ 500R, 65mA @ 2K, 15mA @ 10K | (Not explicitly stated in comparable format) |
Patient Leakage Current ( |
Ask a specific question about this device
Page 1 of 1